Skip to main content

Want a detailed portfolio tracker?

Cassava Sciences (SAVA) P/E

Cassava Sciences (SAVA) P/E from May 28, 2026 to Jun 3, 2026. The TTM Cassava Sciences (SAVA) P/E is -1.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cassava Sciences (SAVA)

YearP/EChange
2026-1.48N/A

Comparison Cassava Sciences (SAVA) P/E with competitors

Cassava Sciences (SAVA) P/E is -1.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.10-106.93%
ENLVEnlivex Therapeutics Ltd0.15-110.18%
FGENFibroGen Inc0.24-116.26%
TRAWTraws Pharma Inc0.47-132.03%
FBIOFortress Biotech Inc0.71-147.84%
CHRSCoherus Biosciences Inc0.98-166.27%
ORMPOramed Pharmaceuticals Inc1.47-199.83%
AGENAgenus Inc2.05-238.79%
VIVSVivoSim Labs Inc2.54-271.81%
INVAInnoviva Inc3.19-316.03%
CRMDCorMedix Inc3.65-347.01%
ABEOAbeona Therapeutics Inc4.20-384.90%
VXRTVaxart Inc4.26-388.74%
CVACCureVac N.V.4.45-401.21%
SRPTSarepta Therapeutics Inc4.62-413.31%
GLPGGalapagos NV4.86-429.20%
RIGLRigel Pharmaceuticals4.92-433.31%
ZVRAZevra Therapeutics Inc4.97-437.01%
ABUSArbutus Biopharma Corp5.69-485.77%
CGENCompugen Ltd7.38-600.29%
AUPHAurinia Pharmaceuticals Inc9.25-726.82%
ACADAcadia Pharmaceuticals Inc9.59-749.63%
OMEROmeros Corporation9.88-769.64%
PLXProtalix BioTherapeutics Inc9.91-771.39%
SPROSpero Therapeutics Inc10.73-827.32%
ADMAAdma Biologics Inc11.33-867.70%
SVASinovac Biotech Ltd11.44-874.84%
TBPHTheravance Biopharma Inc11.78-897.92%
HRMYHarmony Biosciences Holdings Inc12.18-925.28%
TGTXTG Therapeutics Inc13.18-992.97%
INCYIncyte Corp13.38-1006.69%
SABSSAB Biotherapeutics Inc14.06-1052.47%
XOMAXOMA Corp14.95-1112.61%
REGNRegeneron Pharmaceuticals Inc14.98-1114.98%
PBYIPuma Biotechnology Inc15.05-1119.74%
EXELExelixis Inc15.79-1170.17%
NAGENiagen Bioscience Inc16.35-1208.12%
CPRXCatalyst Pharmaceuticals Inc17.34-1275.19%
MDXGMimedx Group Inc17.38-1277.26%
ARGXArgen X SE23.07-1663.21%
HALOHalozyme Therapeutics Inc23.20-1671.95%
XOMAOXOMA Corp25.34-1817.23%
VRTXVertex Pharmaceuticals Inc25.66-1838.30%
XOMAPXOMA Corp25.67-1839.27%
CTMXCytomX Therapeutics Inc25.70-1841.15%
ASNDAscendis Pharma A/S26.35-1885.61%
RPRXRoyalty Pharma plc - Class A27.50-1962.94%
SLNOSoleno Therapeutics Inc29.02-2065.92%
LGNDLigand Pharmaceuticals Inc - Class B30.19-2145.28%
BMRNBiomarin Pharmaceutical Inc37.51-2641.29%
APLSApellis Pharmaceuticals Inc39.02-2743.87%
KRYSKrystal Biotech Inc39.70-2789.70%
GMABGenmab40.20-2823.98%
ONCBeiGene Ltd67.03-4641.39%
TECHBio-Techne Corp68.59-4747.64%
VCELVericel Corp80.63-5563.01%
PHARPharming Group N.V.87.74-6044.81%
ALNYAlnylam Pharmaceuticals Inc124.93-8564.85%
TLXTelix Pharmaceuticals Ltd139.89-9578.26%
CORTCorcept Therapeutics Inc158.39-10831.62%